Is 2-FDCK legal in New Zealand?

Legal status

Controlled through the open analogue limb rather than by a schedule name. 2-FDCK, a fluorinated arylcyclohexylamine sold in place of ketamine, has no entry of its own in Schedules 1 to 3 on the text cited, and this finding does not rest on that absence: the Misuse of Drugs Act 1975 defines a controlled drug analogue as any substance whose structure is substantially similar to that of a controlled drug, subject to the stated exclusions, and the stated parent structure places 2-FDCK in that limb unless a medicine exclusion or an express exclusion applies. The analogue route lands in Schedule 3 Part 7, so the class is C. Ketamine has its own row here and is named in Schedule 2 as Class B, so the substitute is reached at Class C through the analogue limb while the thing it substitutes for is Class B. The dossier states the statutory route rather than claiming a laboratory determination, because a court-grade analogue conclusion can depend on expert structural evidence. This was read against the consolidation current at 20 September 2026; the 2026 Classification and Presumption of Supply Order was made but no commencement instrument was located by that horizon, so nothing it proposes is treated as law here.

Consequences if caught

Capital exposure: none. New Zealand has no death penalty. A controlled drug analogue is treated as a Class C controlled drug, so the exposure on 2-FDCK is the section 6 dealing maximum of 8 years, with section 7 reaching possession. This row's own ceiling column states the section 7 limb without attaching a figure to it, and the Class C rows in this table put that possession maximum at 3 months. The 8 year figure is the whole of the exposure on this route. A person who believes they are handling a named anaesthetic is on the analogue route instead, and a 6 year difference in ceiling turns on one fluorine atom.

If prescribed or medical

Not established for a traveller. This dossier carries no country-level rule for entering New Zealand with a prescribed medicine: it records that medicines status has to be checked alongside the analogue exclusions and the Psychoactive Substances Act 2013 route, and that a court-grade conclusion can turn on the medicine exclusions, but it states no declaration requirement, no permit, no quantity allowance and no carry limit at the border, and none was researched for this cell. What is established is the placement a traveller would be read against: 2-FDCK is not named in Schedules 1 to 3 and is reached, if at all, through the section 2 controlled-drug-analogue limb, which is treated as Class C. It is sold as a substitute for a clinical anaesthetic, which is precisely why no medicines answer can be assumed to apply to it. Do not read that placement as a ruling on a lawfully prescribed and lawfully carried supply, which is a different question this cell does not answer. Settle the border question with the Ministry of Health, whose classification order implementation page this dossier cites, and with the New Zealand border authority, before travelling.

Documentation

Carry the Misuse of Drugs Act 1975 consolidation current at 20 September 2026 and read section 2 together with Schedule 3 Part 7, because neither carries the finding for 2-FDCK on its own. Read the section 2 analogue definition against the Schedule 2 ketamine entry, since 2-FDCK is not named anywhere in Schedules 1 to 3. Carry the point that an absent name is not an answer in New Zealand: the list is closed for named substances while the analogue limb is open, so a search of the schedules that returns nothing has not finished the question. Carry the classification chain this finding was read against as well: the 2022 and 2025 Classification and Presumption of Supply Orders with their commencement orders, the 2024 pseudoephedrine amendment, and the 2026 Order, which was made but is not treated as law in this dossier because its own section 2 leaves commencement to the Governor-General and no commencement instrument was located by the horizon. Carry the date as well, 20 September 2026, because in New Zealand a classification order can move a substance between classes without a word of the Act changing.

Drug laws and enforcement change and vary within a country. This is not legal advice. Always confirm with New Zealand’s embassy or official drug authority before traveling; penalties can be severe, including imprisonment.